logo

For the Inventor, By the Inventor

Suwon-si, South Korea

Medicinal Bioconvergence Research Center


USPTO Granted Patents = 18



Forward Citations = 8

Loading Chart...
Loading Chart...

33 inventors (with patents filed for the assignee):

goldMedal Sunghoon Kim (16 out of 131 patents)

silverMedal Dae Gyu Kim (4 out of 8 patents)

bronzeMedal Jin Woo Choi (4 out of 98 patents)

4.  Min Chul Park (4 out of 15 patents)

5.  Chul Ho Lee (2 out of 57 patents)

6.  Inwon Park (2 out of 2 patents)

7.  Pil Han Kim (2 out of 2 patents)

8.  Jung Min Han (2 out of 5 patents)

9.  Nam Hoon Kwon (1 out of 6 patents)

10.  Peter Charles Goughnour (1 out of 1 patent)

11.  Yeseul Kim (1 out of 2 patents)

12.  Joon-Sung Park (1 out of 5 patents)

13.  Kyunggon Kim (1 out of 1 patent)

14.  Jee Sun Yang (1 out of 1 patent)

15.  Yon-Sik Choi (1 out of 1 patent)


18 patents:

1. 11649231 - Compound as mTOR inhibitor and use thereof (2023-05-16),
2. 11442057 - Method for screening anticancer agent inhibiting binding of AIMP2-DX2 and HSP70 (2022-09-13),
3. 11360093 - Colorectal cancer diagnostic composition, and method for detecting diagnostic marker (2022-06-14),
4. 11173192 - Anti-RNA virus composition comprising EPRS protein or fragment thereof (2021-11-16),
5. 11029504 - Window apparatus for obtaining microscopic image of in vivo breast tissue and method for obtaining image using same (2021-06-08),
6. 10677806 - Composition for diagnosing follicular thyroid carcinoma using expression level of aminoacyl-tRNA synthetase-related protein and method for detecting diagnostic marker (2020-06-09),
7. 10646547 - Polypeptide having chemokine activity and uses thereof (2020-05-12),
8. 10437035 - Microaspiration-based lung window apparatus for obtaining microscopic image of in vivo lung tissue and method for obtaining image using same (2019-10-08),
9. 10258674 - Nanoparticles comprising aminoacyl tRNA synthetase and anticancer composition comprising same (2019-04-16),
10. 10139394 - Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase (2018-11-27),
11. 10130611 - Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis (2018-11-20),
12. 9945859 - Anti-KRS monoclonal antibody and use thereof (2018-04-17),
13. 9944713 - Antibody specific to the AIMP2-DX2 (2018-04-17),
14. 9539236 - Pharmaceutical composition for preventing or treating cancer (2017-01-10),
15. 9511085 - Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase (2016-12-06),
Medicinal Bioconvergence Research Center is a leading research facility specializing in the development of innovative medical treatments. Their mission is to advance medical science through a multidisciplinary approach, combining biology, chemistry, and nanotechnology. With state-of-the-art laboratories and a team of renowned scientists, they strive to revolutionize healthcare by discovering novel medicines and therapies that can improve the lives of people worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

18 Patents

#16 in Suwon-si

#651 in South Korea

#33,147 in the World

...
Suwon-si, South Korea

Medicinal Bioconvergence Research Center

Forward Citations = 8

33 inventors:

goldMedal Sunghoon Kim (16 out of 131 patents)

silverMedal Dae Gyu Kim (4 out of 8 patents)

bronzeMedal Jin Woo Choi (4 out of 98 patents)

4.  Min Chul Park (4 out of 15 patents)

5.  Chul Ho Lee (2 out of 57 patents)

Please report any incorrect information to support@idiyas.com
Loading…